LPCN (STOCKS)
Lipocine Inc.
$2.060000
+0.000000 (+0.00%)
Prev close: $2.060000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Mahesh V. Patel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $17.23M
- Employees
- 16
- P/E (TTM)
- -1.11
- P/B (TTM)
- 0.78
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-0.32 | $-0.44 | +0.1237 | +27.88% |
|
Mar 2026 (Q1)
|
$-0.54 | $-0.49 | -0.0453 | -9.16% |
|
Dec 2025 (Q4)
|
$-0.42 | $-0.62 | +0.2022 | +32.50% |
|
Sep 2025 (Q3)
|
$-0.59 | $-0.55 | -0.0392 | -7.12% |
Financial Statements
| Revenues | $1.57M |
| Benefits Costs and Expenses | $13.42M |
| Costs And Expenses | $13.00M |
| Nonoperating Income/Loss | $717.35K |
| Operating Expenses | $14.14M |
| Depreciation and Amortization | $58.57K |
| Research and Development | $10.19M |
| Other Operating Expenses | $3.90M |
| Operating Income/Loss | -$12.57M |
| Income/Loss From Continuing Operations After Tax | -$11.85M |
| Income/Loss From Continuing Operations Before Tax | -$11.85M |
| Net Income/Loss | -$11.85M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$11.85M |
| Net Income/Loss Available To Common Stockholders, Basic | -$11.85M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Average Shares | 13,000,485 |
| Diluted Average Shares | 13,259,852 |
| Assets | $23.84M |
| Current Assets | $23.74M |
| Noncurrent Assets | $98.58K |
| Fixed Assets | $74.83K |
| Other Non-current Assets | $23.75K |
| Liabilities | $2.07M |
| Current Liabilities | $2.07M |
| Accounts Payable | $680.53K |
| Other Current Liabilities | $1.39M |
| Noncurrent Liabilities | $0.00 |
| Equity | $21.77M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $21.77M |
| Liabilities And Equity | $23.84M |
| Net Cash Flow From Operating Activities | -$11.19M |
| Net Cash Flow From Operating Activities, Continuing | -$11.19M |
| Net Cash Flow From Investing Activities | -$6.15M |
| Net Cash Flow From Investing Activities, Continuing | -$6.15M |
| Net Cash Flow From Financing Activities | $16.27M |
| Net Cash Flow From Financing Activities, Continuing | $16.27M |
| Net Cash Flow | -$1.06M |
| Net Cash Flow, Continuing | -$1.06M |
| Comprehensive Income/Loss | -$11.86M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$11.86M |
| Other Comprehensive Income/Loss | -$11.86M |